Superior outcome of upfront allogeneic hematopoietic cell transplantation versus hypomethylating agent induction in myelodysplastic syndrome

被引：6

作者：

Schroeder, Jan Christian ^{[1
]}

Mix, Lucas ^{[1
]}

Faustmann, Philipp ^{[1
]}

Weller, Jan Frederic ^{[1
]}

Fehn, Adrian ^{[1
]}

Phely, Laurent ^{[1
]}

Riedel, Andreas ^{[1
]}

Vogel, Wichard ^{[1
]}

Faul, Christoph ^{[1
]}

Lengerke, Claudia ^{[1
]}

Bethge, Wolfgang Andreas ^{[1
]}

机构：

[1] Univ Hosp Tuebingen, Dept Internal Med Hematol Oncol Clin Immunol & Rhe, Tubingen, Germany

来源：

BONE MARROW TRANSPLANTATION | 2024年 / 59卷 / 09期

关键词：

ACUTE MYELOID-LEUKEMIA; MDS;

D O I：

10.1038/s41409-024-02365-5

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

页码：1332 / 1334

页数：3

共 12 条

[1] Should Cytoreductive Treatment Be Performed Before Transplantation in Patients With High-Risk Myelodysplastic Syndrome? [J].

Alessandrino, Emilio Paolo ;

Della Porta, Matteo Giovanni ;

Pascutto, Cristiana ;

Bacigalupo, Andrea ;

Rambaldi, Alessandro .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (21) :2761-2762

[2] Upfront transplantation may have better outcomes than pretransplant cytoreductive therapy for treating patients with MDS-EB-1 or MDS-EB-2 [J].

Chen, Yili ;

Huang, Fen ;

Xuan, Li ;

Zhang, Yu ;

Fan, Zhiping ;

Xu, Na ;

Zhao, Ke ;

Xu, Jun ;

Liu, Hui ;

Shi, Pengcheng ;

Wang, Zhixiang ;

Sun, Jing ;

Zheng, Weiyang ;

Dai, Min ;

Liu, Qifa .

INTERNATIONAL JOURNAL OF CANCER, 2021, 149 (05) :1109-1120

[3] Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel [J].

de Witte, Theo ;

Bowen, David ;

Robin, Marie ;

Malcovati, Luca ;

Niederwieser, Dietger ;

Yakoub-Agha, Ibrahim ;

Mufti, Ghulam J. ;

Fenaux, Pierre ;

Sanz, Guillermo ;

Martino, Rodrigo ;

Alessandrino, Emilio Paolo ;

Onida, Francesco ;

Symeonidis, Argiris ;

Passweg, Jakob ;

Kobbe, Guido ;

Ganser, Arnold ;

Platzbecker, Uwe ;

Finke, Jurgen ;

van Gelder, Michel ;

van de Loosdrecht, Arjan A. ;

Ljungman, Per ;

Stauder, Reinhard ;

Volin, Liisa ;

Deeg, H. Joachim ;

Cutler, Corey ;

Saber, Wael ;

Champlin, Richard ;

Giralt, Sergio ;

Anasetti, Claudio ;

Kroeger, Nicolaus .

BLOOD, 2017, 129 (13) :1753-1762

[4] Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN [J].

Doehner, Hartmut ;

Wei, Andrew H. ;

Appelbaum, Frederick R. ;

Craddock, Charles ;

DiNardo, Courtney D. ;

Dombret, Herve ;

Ebert, Benjamin L. ;

Fenaux, Pierre ;

Godley, Lucy A. ;

Hasserjian, Robert P. ;

Larson, Richard A. ;

Levine, Ross L. ;

Miyazaki, Yasushi ;

Niederwieser, Dietger ;

Ossenkoppele, Gert ;

Roellig, Christoph ;

Sierra, Jorge ;

Stein, Eytan M. ;

Tallman, Martin S. ;

Tien, Hwei-Fang ;

Wang, Jianxiang ;

Wierzbowska, Agnieszka ;

Lowenberg, Bob .

BLOOD, 2022, 140 (12) :1345-1377

[5] Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia [J].

Kantarjian, Hagop M. ;

Thomas, Xavier G. ;

Dmoszynska, Anna ;

Wierzbowska, Agnieszka ;

Mazur, Grzegorz ;

Mayer, Jiri ;

Gau, Jyh-Pyng ;

Chou, Wen-Chien ;

Buckstein, Rena ;

Cermak, Jaroslav ;

Kuo, Ching-Yuan ;

Oriol, Albert ;

Ravandi, Farhad ;

Faderl, Stefan ;

Delaunay, Jacques ;

Lysak, Daniel ;

Minden, Mark ;

Arthur, Christopher .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (21) :2670-2677

[6] Intensive chemotherapy is not recommended for patients aged >60 years who have myelodysplastic syndromes or acute myeloid leukemia with high-risk karyotypes [J].

Knipp, Sabine ;

Hildebrand, Barbara ;

Kuendgen, Andrea ;

Giagounidis, Aristoteles ;

Kobbe, Guido ;

Haas, Rainer ;

Aul, Carlo ;

Gattermann, Norbert ;

Germing, Ulrich .

CANCER, 2007, 110 (02) :345-352

[7] Comparison Between 5-Azacytidine Treatment and Allogeneic Stem-Cell Transplantation in Elderly Patients With Advanced MDS According to Donor Availability (VidazaAllo Study) [J].

Kroeger, Nicolaus ;

Sockel, Katja ;

Wolschke, Christine ;

Bethge, Wolfgang ;

Schlenk, Richard F. ;

Wolf, Dominik ;

Stadler, Michael ;

Kobbe, Guido ;

Wulf, Gerald ;

Bug, Gesine ;

Schaefer-Eckart, Kerstin ;

Scheid, Christof ;

Nolte, Florian ;

Kroenke, Jan ;

Stelljes, Matthias ;

Beelen, Dietrich ;

Heinzelmann, Marion ;

Haase, Detlef ;

Buchner, Hannes ;

Bleckert, Gabriele ;

Giagounidis, Aristoteles ;

Platzbecker, Uwe .

JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (30) :3318-+

[8] Allogeneic Hematopoietic Cell Transplantation in Patients Age 60-70 Years with De Novo High-Risk Myelodysplastic Syndrome or Secondary Acute Myelogenous Leukemia: Comparison with Patients Lacking Donors Who Received Azacitidine [J].

Platzbecker, Uwe ;

Schetelig, Johannes ;

Finke, Juergen ;

Trenschel, Rudolf ;

Scott, Bart L. ;

Kobbe, Guido ;

Schaefer-Eckart, Kerstin ;

Bornhaeuser, Martin ;

Itzykson, Raphael ;

Germing, Ulrich ;

Beelen, Dietrich ;

Ehninger, Gerhard ;

Fenaux, Pierre ;

Deeg, H. Joachim ;

Ades, Lionel .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (09) :1415-1421

[9] Upfront Allogeneic Blood Stem Cell Transplantation for Patients with High-Risk Myelodysplastic Syndrome or Secondary Acute Myeloid Leukemia Using a FLAMSA-Based High-Dose Sequential Conditioning Regimen [J].

Saure, Christian ;

Schroeder, Thomas ;

Zohren, Fabian ;

Groten, Anke ;

Bruns, Ingmar ;

Czibere, Akos ;

Galonska, Lars ;

Kondakci, Mustafa ;

Weigelt, Christian ;

Fenk, Roland ;

Germing, Ulrich ;

Haas, Rainer ;

Kobbe, Guido .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (03) :466-472

[10] Comparison between Upfront Transplantation and different Pretransplant Cytoreductive Treatment Approaches in Patients with High-Risk Myelodysplastic Syndrome and Secondary Acute Myelogenous Leukemia [J].

Schroeder, Thomas ;

Wegener, Nadija ;

Lauseker, Michael ;

Rautenberg, Christina ;

Nachtkamp, Kathrin ;

Schuler, Esther ;

Kondakci, Mustafa ;

Haas, Rainer ;

Germing, Ulrich ;

Kobbe, Guido .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (08) :1550-1559

← 1 2 →